Perla, Yollinda C.
HRN: 01-62-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2023
CEFUROXIME 500MG (TAB)
06/07/2023
06/14/2023
PO
500 Mg
Every 12 Hours
S/P Repeat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive TractProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes